Nanoco has announced plans to delist from the London Stock Exchange’s Main Market and re-register as a private company, subject to shareholder approval. Management believes the move will reduce annual costs by c £0.7m, extending the group’s cash runway, while providing greater flexibility to commercialise its portfolio. A shareholder vote will take place on 19 June 2026, with delisting expected to become effective on 20 July 2026. Following delisting, shareholders will still be able to trade shares through a matched bargain facility operated by JP Jenkins.

Nanoco’s H126 results show continued delivery on its joint development agreement (JDA) engagements, with its lead programme progressing towards scale-up and negotiations ongoing for further work with its second. With a strong balance sheet and enterprise value near zero, further milestones could act as catalysts for upside.

Nanoco Group’s announcement that the CDX process has ended without an acceptable offer for its business operations is clearly a setback. Focus now turns solely to pursuing commercial opportunities in sensors and monetising the company’s display intellectual property (IP). While execution risk remains significant, we believe that Nanoco’s IP, balance sheet, commercial and litigation activities continue to provide a platform to deliver shareholder upside. The delivery of further joint development agreement (JDA) milestones and a positive litigation outcome with Shoei Chemical are the key proof points to understand valuation potential.